Today: 4 July 2026
Browse Category

NASDAQ:CRVS 21 January 2026

Corvus Pharmaceuticals stock whipsaws: CRVS slides after $150 million offering follows eczema data surge

Corvus Pharmaceuticals stock whipsaws: CRVS slides after $150 million offering follows eczema data surge

New York, January 21, 2026, 05:35 ET — Premarket Shares of Corvus Pharmaceuticals, Inc. dropped nearly 8%, slipping to $19.68 in premarket trading Wednesday. The decline follows the company's announcement of an underwritten public offering worth $150 million in common stock and pre-funded warrants. These warrants let investors lock in shares now by paying most of the price upfront, with the option to buy later. Jefferies and Goldman Sachs are heading the deal, which also includes a 30-day over-allotment option allowing underwriters to purchase an extra $22.5 million in shares.
21 January 2026
···

Stock Market Today

  • Data Points to $1 Trillion Institutional Test for Bitcoin’s Next Leg Higher
    July 4, 2026, 7:04 AM EDT. It now takes much more money to push Bitcoin higher than before. A decade ago, $5 million could double the price-now cycles need over $100 billion. CryptoQuant founder Ki Young Ju said it may take $1 trillion or more in new institutional funds for Bitcoin to see another big rally, turning it into a serious macro position instead of a retail trade. The comments follow record outflows from spot bitcoin ETFs in the U.S. and a weak first half for the token, as some doubt whether institutions can actually step up their buying. Analysts warn returns shrink as assets age, and it's unclear if big institutional flows will materialize.
Go toTop